Fentanyl Market Size & Share, by Route of Administration (Sublingual Tablet, Buccal Tablet, Oral Film); End-user (Hospital, Oncology Centers, Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3762
  • Published Date: Mar 31, 2023
  • Report Format: PDF, PPT

Companies Dominating the Fentanyl Landscape

    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Boehringer Ingelheim GmbH
    • Bayer AG
    • Novartis AG
    • Sanofi-aventis Groupe
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Validus Pharmaceuticals LLC
    • Teva Pharmaceutical Industries Ltd.
    • Siemens Healthcare GmbH

Browse Key Market Insights with Data Illustration:


In The News

  • The Drug Enforcement Administration (DEA) has issued a safety alert about a surge in counterfeit prescription drugs containing alarming levels of fentanyl and stimulants.

  • The Washington State Department of Health and Human Services has warned that fentanyl overdoses are on the rise in the United States. These tablets contain large amounts of illicit fentanyl of varying purity and potency. Overdose mortality increased significantly in 2021. 



Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3762
  • Published Date: Mar 31, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing incidences of cancer and the growing oncology spending are the major factors driving the growth of the fentanyl market.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

The side effects of narcotics are the challenges affecting the market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Bayer AG, Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Siemens Healthcare GmbH, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by route of administration, end-user, and by region.

The oncology centers segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying